Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China flag China · Delayed Price · Currency is CNY
13.04
+0.14 (1.09%)
Jul 31, 2026, 3:05 PM CST

SHE:300122 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
1,7092,6262,7066,3412,6224,308
Trading Asset Securities
--11.53---
Cash & Short-Term Investments
1,7092,6262,7176,3412,6224,308
Cash Growth
-44.30%-3.37%-57.15%141.81%-39.13%199.68%
Accounts Receivable
10,92511,16516,30227,05920,61412,868
Other Receivables
64.47148.1210.977.88.396.87
Receivables
10,98911,31316,31327,06620,62212,874
Inventory
3,5735,00322,2448,9868,0207,385
Prepaid Expenses
-0.144.919.73-0.59
Other Current Assets
145.8977.16124.31111.37148.53185.63
Total Current Assets
16,41819,01941,40342,51431,41324,754
Property, Plant & Equipment
5,7645,8806,1655,1204,6933,557
Long-Term Investments
289.35289.35295295284.5239
Goodwill
19.2819.2819.2819.2819.2819.28
Other Intangible Assets
561.56574.48346.25317.68352.71342.8
Long-Term Deferred Tax Assets
3,7483,697966.88569.19186.08115.34
Long-Term Deferred Charges
2,1372,0901,8711,088731.97485.04
Other Long-Term Assets
154.96150.07231.11308.42322.5534.91
Total Assets
29,09231,72051,29750,23238,00430,047

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
439.221,2415,82313,1429,8079,178
Accrued Expenses
27.71578.71522.161,6731,2401,090
Short-Term Debt
560.048,59411,9022,6351,785568.86
Current Portion of Long-Term Debt
2,878765.6285.0136.41--
Current Portion of Leases
-9.211.7710.29.810.25
Current Income Taxes Payable
20.096.5386.86434.59347.7933.25
Current Unearned Revenue
58.9483.411.8711.31--
Other Current Liabilities
1,2441,125418.82143.8640.1799.62
Total Current Liabilities
5,22812,40418,86118,08613,23011,871
Long-Term Debt
7,8582,9091,242328.08210.64236.41
Long-Term Leases
7.849.5416.6725.3127.7612.24
Long-Term Unearned Revenue
250.08256.05281.68228.27238.34222.2
Long-Term Deferred Tax Liabilities
35.6635.6644.3157.9660.7748.34
Total Liabilities
13,38015,61420,44618,72613,76812,390

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
2,3942,3942,3942,4001,6001,600
Additional Paid-In Capital
210.19210.19197.8847.96207.96207.96
Retained Earnings
12,84713,23628,26229,05822,42815,849
Total Common Equity
15,45115,84030,85431,50624,23617,657
Minority Interest
260.97266.35-2.23---
Shareholders' Equity
15,71216,10630,85131,50624,23617,657
Total Liabilities & Equity
29,09231,72051,29750,23238,00430,047

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
11,30412,28713,2573,0352,033817.76
Net Cash (Debt)
-9,595-9,662-10,5403,305588.943,490
Net Cash Growth
---461.19%-83.13%-
Net Cash Per Share
-4.01-4.04-4.401.380.251.45
Filing Date Shares Outstanding
2,3942,3942,3942,4002,4002,400
Total Common Shares Outstanding
2,3942,3942,3942,4002,4002,400
Working Capital
11,1906,61522,54224,42818,18312,883
Book Value Per Share
6.456.6212.8913.1310.107.36
Tangible Book Value
14,87115,24630,48831,16923,86417,295
Tangible Book Value Per Share
6.216.3712.7412.999.947.21
Buildings
-2,8802,8402,5221,7051,042
Machinery
-3,6053,3962,5262,0641,369
Construction In Progress
-1,5471,5851,2871,8361,825